Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Supreme Pharmaceuticals Appoints New Director

|Includes: Supreme Pharmaceuticals, Inc. (SPRWF)

Supreme Pharmaceuticals (CVE:SL, CNSX:SL), a developer of medical marijuana, has appointed Navdeep Dhaliwal as a director.

Dhaliwal's primary focus will be the development of Supreme's go-to-market strategy, in addition to corporate development and capital markets initiatives, the Vancouver, British Columbia-based company said in a statement on Thursday.

"This is an exciting time for Supreme," Dhaliwal was quoted in the statement as saying. "I am looking forward to working with Supreme's leadership team to leverage my experiences growing businesses, particularly in the on-line space."

Dhaliwal is a chartered accountant and currently serves as th principal of NLX Capital, a Toronto-based corporate development firm focused primarily on technology and renewable energy.

Dhaliwal was recently retained by a Toronto software company where he successfully expanded the company's business into South East Asia, where Dhaliwal has extensive business experience.

Dhaliwal has been involved in the Canadian medical marijuana space for two years prior to joining Supreme.

Concurrent with Dhaliwal's appointment, Supreme's board accepted the resignation of Allan Levien, a long-serving director of the company.